Women around the world are impacted by diabetes in many ways. Over half of the diabetes population are women, and many women (both with Type 1 and Type 2 diabetes) will have pregnancies during their disease exposure. The incidence of gestational diabetes (GDM) also continues to rise, hence it has been
GDM affects 3-5% of all pregnancies world-wide. While epidemiological evidence linking history of GDM and development of Type II DM later in life among women is strong, the relation of in utero exposure of diabetes on the pregnancy off-spring has been inconsistent.
Women newly diagnosed with Gestational Diabetes Mellitus (GDM) face a steep learning curve. The diagnosis of GDM channels women into a medicalised antenatal care pathway, requiring additional monitoring and intervention. Diagnosed with a new condition during an otherwise normal pregnancy women suddenly come face to face with the requirement to